| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $398.0K | $436.0K | $497.0K |
| YoY Revenue Growth % | -8.7% | -12.3% | — |
| Gross Profit | $258.0K | $264.0K | — |
| Gross Margin % | 64.8% | 60.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.2M | -$12.7M | -$16.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$12.1M | -$11.1M | -$18.4M |
| EBITDA (Normalized) | -$12.2M | -$12.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.5M | -$11.1M | -$14.9M |
| Capital Expenditures (CapEx) | $25.0K | $62.0K | — |
| Free Cash Flow (FCF) | -$10.5M | -$11.1M | -$14.9M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $6.2M | $7.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $6.2M | $6.1M | — |